Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5931 | 1557 | 45.3 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
631 | 3 | KYNURENINE//NEOPTERIN//INDOLEAMINE 2 3 DIOXYGENASE | 12928 |
2074 | 2 | KYNURENINE//NEOPTERIN//INDOLEAMINE 2 3 DIOXYGENASE | 5255 |
5931 | 1 | INDOLEAMINE 2 3 DIOXYGENASE//INDOLEAMINE 2//IDO | 1557 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INDOLEAMINE 2 3 DIOXYGENASE | authKW | 3653047 | 20% | 59% | 316 |
2 | INDOLEAMINE 2 | authKW | 989639 | 5% | 62% | 81 |
3 | IDO | authKW | 983826 | 7% | 45% | 112 |
4 | 3 DIOXYGENASE | authKW | 800682 | 4% | 58% | 70 |
5 | KYNURENINE | authKW | 482210 | 8% | 19% | 128 |
6 | INDOLEAMINE 2 3 DIOXYGENASE IDO | authKW | 323306 | 2% | 63% | 26 |
7 | TRYPTOPHAN | authKW | 253398 | 13% | 7% | 197 |
8 | 1 METHYL TRYPTOPHAN | authKW | 245120 | 1% | 83% | 15 |
9 | INDOLEAMINE DIOXYGENASE | authKW | 244359 | 1% | 69% | 18 |
10 | IDO1 | authKW | 226680 | 1% | 68% | 17 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 6872 | 32% | 0% | 506 |
2 | Biochemistry & Molecular Biology | 831 | 23% | 0% | 353 |
3 | Medicine, Research & Experimental | 729 | 9% | 0% | 142 |
4 | Oncology | 585 | 12% | 0% | 186 |
5 | Cell Biology | 377 | 10% | 0% | 154 |
6 | Chemistry, Medicinal | 257 | 5% | 0% | 71 |
7 | Hematology | 253 | 5% | 0% | 73 |
8 | Transplantation | 249 | 3% | 0% | 47 |
9 | Allergy | 127 | 2% | 0% | 24 |
10 | Biophysics | 96 | 4% | 0% | 62 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INFORMAT CLIN MED | 191199 | 2% | 30% | 32 |
2 | CENT BLOOD TRANSFUS IMMUNOL | 137588 | 1% | 35% | 20 |
3 | PROGRAM MOL IMMUNOL | 103862 | 1% | 38% | 14 |
4 | MOL IMMUNOPATHOL UNIT | 66154 | 1% | 19% | 18 |
5 | BIOCHEM PL SCI | 58830 | 0% | 100% | 3 |
6 | PL SCI BIOCHEM | 58830 | 0% | 100% | 3 |
7 | AUSTRALIAN CATARACT FDN | 57119 | 1% | 22% | 13 |
8 | LONGEV SCI | 40734 | 2% | 9% | 24 |
9 | INTERNAL MEDKALAFONG HOSP | 39220 | 0% | 100% | 2 |
10 | MITOCHONDRIA SIGNALING MED | 39220 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CURRENT DRUG METABOLISM | 3486 | 1% | 1% | 14 |
2 | ONCOIMMUNOLOGY | 2933 | 1% | 1% | 12 |
3 | JOURNAL OF IMMUNOLOGY | 2355 | 5% | 0% | 82 |
4 | JOURNAL OF INTERFERON AND CYTOKINE RESEARCH | 2205 | 1% | 1% | 16 |
5 | JOURNAL OF INTERFERON RESEARCH | 1620 | 1% | 1% | 9 |
6 | PTERIDINES | 1204 | 0% | 1% | 5 |
7 | JOURNAL OF REPRODUCTIVE IMMUNOLOGY | 970 | 1% | 1% | 10 |
8 | TRANSPLANT IMMUNOLOGY | 832 | 0% | 1% | 7 |
9 | FRONTIERS IN IMMUNOLOGY | 797 | 1% | 0% | 11 |
10 | IMMUNOLOGY LETTERS | 773 | 1% | 0% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INDOLEAMINE 2 3 DIOXYGENASE | 3653047 | 20% | 59% | 316 | Search INDOLEAMINE+2+3+DIOXYGENASE | Search INDOLEAMINE+2+3+DIOXYGENASE |
2 | INDOLEAMINE 2 | 989639 | 5% | 62% | 81 | Search INDOLEAMINE+2 | Search INDOLEAMINE+2 |
3 | IDO | 983826 | 7% | 45% | 112 | Search IDO | Search IDO |
4 | 3 DIOXYGENASE | 800682 | 4% | 58% | 70 | Search 3+DIOXYGENASE | Search 3+DIOXYGENASE |
5 | KYNURENINE | 482210 | 8% | 19% | 128 | Search KYNURENINE | Search KYNURENINE |
6 | INDOLEAMINE 2 3 DIOXYGENASE IDO | 323306 | 2% | 63% | 26 | Search INDOLEAMINE+2+3+DIOXYGENASE+IDO | Search INDOLEAMINE+2+3+DIOXYGENASE+IDO |
7 | TRYPTOPHAN | 253398 | 13% | 7% | 197 | Search TRYPTOPHAN | Search TRYPTOPHAN |
8 | 1 METHYL TRYPTOPHAN | 245120 | 1% | 83% | 15 | Search 1+METHYL+TRYPTOPHAN | Search 1+METHYL+TRYPTOPHAN |
9 | INDOLEAMINE DIOXYGENASE | 244359 | 1% | 69% | 18 | Search INDOLEAMINE+DIOXYGENASE | Search INDOLEAMINE+DIOXYGENASE |
10 | IDO1 | 226680 | 1% | 68% | 17 | Search IDO1 | Search IDO1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | YEUNG, AWS , TERENTIS, AC , KING, NJC , THOMAS, SR , (2015) ROLE OF INDOLEAMINE 2,3-DIOXYGENASE IN HEALTH AND DISEASE.CLINICAL SCIENCE. VOL. 129. ISSUE 7. P. 601 -672 | 385 | 69% | 13 |
2 | TAN, PH , BHARATH, AK , (2009) MANIPULATION OF INDOLEAMINE 2,3 DIOXYGENASE; A NOVEL THERAPEUTIC TARGET FOR TREATMENT OF DISEASES.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 13. ISSUE 8. P. 987 -1012 | 151 | 68% | 19 |
3 | JOHNSON, TS , MUNN, DH , (2012) HOST INDOLEAMINE 2,3-DIOXYGENASE: CONTRIBUTION TO SYSTEMIC ACQUIRED TUMOR TOLERANCE.IMMUNOLOGICAL INVESTIGATIONS. VOL. 41. ISSUE 6-7. P. 765 -797 | 129 | 66% | 21 |
4 | ROHRIG, UF , MAJJIGAPU, SR , VOGEL, P , ZOETE, V , MICHIEIN, O , (2015) CHALLENGES IN THE DISCOVERY OF INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) INHIBITORS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 58. ISSUE 24. P. 9421 -9437 | 86 | 77% | 15 |
5 | MELLOR, AL , MUNN, DH , (2004) IDO EXPRESSION BY DENDRITIC CELLS: TOLERANCE AND TRYPTOPHAN CATABOLISM.NATURE REVIEWS IMMUNOLOGY. VOL. 4. ISSUE 10. P. 762-774 | 82 | 60% | 1161 |
6 | DI PUCCHIO, T , DANESE, S , DE CRISTOFARO, R , RUTELLA, S , (2010) INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE: A REVIEW OF NOVEL PATENTED LEAD COMPOUNDS.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 20. ISSUE 2. P. 229-250 | 121 | 72% | 19 |
7 | LIU, X , NEWTON, RC , FRIEDMAN, SM , SCHERLE, PA , (2009) INDOLEAMINE 2,3-DIOXYGENASE, AN EMERGING TARGET FOR ANTI-CANCER THERAPY.CURRENT CANCER DRUG TARGETS. VOL. 9. ISSUE 8. P. 938-952 | 94 | 93% | 24 |
8 | MCGAHA, TL , HUANG, L , LEMOS, H , METZ, R , MAUTINO, M , PRENDERGAST, GC , MELLOR, AL , (2012) AMINO ACID CATABOLISM: A PIVOTAL REGULATOR OF INNATE AND ADAPTIVE IMMUNITY.IMMUNOLOGICAL REVIEWS. VOL. 249. ISSUE . P. 135-157 | 115 | 66% | 24 |
9 | JOHNSON, BA , BABAN, B , MELLOR, AL , (2009) TARGETING THE IMMUNOREGULATORY INDOLEAMINE 2,3 DIOXYGENASE PATHWAY IN IMMUNOTHERAPY.IMMUNOTHERAPY. VOL. 1. ISSUE 4. P. 645-661 | 97 | 84% | 33 |
10 | GONZALEZ, A , VARO, N , ALEGRE, E , DIAZ, A , MELERO, I , (2008) IMMUNOSUPPRESSION ROUTED VIA THE KYNURENINE PATHWAY: A BIOCHEMICAL AND PATHOPHYSIOLOGIC APPROACH.ADVANCES IN CLINICAL CHEMISTRY, VOL 45. VOL. 45. ISSUE . P. 155 -197 | 120 | 66% | 22 |
Classes with closest relation at Level 1 |